Carbamazepine (Compound)

Synonyms:carbamazepine, 298-46-4, Tegretol, Carbamazepen, Finlepsin, Biston, 5H-Dibenzo[b,f]azepine-5-carboxamide, Equetro, Tegretal, 5H-Dibenz[b,f]azepine-5-carboxamide, Carbazepine, Neurotol, Epitol, Timonil, Carbamezepine, Carbatrol, Karbamazepin, Stazepine, Telesmin, Lexin, Tegretol-Xr, benzo[b][1]benzazepine-11-carboxamide, Carbamazepinum, Teril, Geigy 32883, 5H-Dibenz(b,f)azepine-5-carboxamide, Carbamazepin, Carbamazepina, Amizepin, Bipotrol, Carnexiv, Sirtal, 5-Carbamyl-5H-dibenzo(b,f)azepine, 5-Carbamoyl-5H-dibenzo(b,f)azepine, Calepsin, Carbamazepine Anhydrous, 5-Carbamoyl-5H-dibenz(b,f)azepine, 5-Carbamoyl-5H-dibenz[b,f]azepine, G-32883, G 32883, Karbelex, Neurotop, NSC 169864, MFCD00005073, CHEBI:3387, CHEMBL108, NSC-169864, Carbamazepine extended release, 5-Carbamyldibenzo(b,f)azepine, MLS000069652, 5-Carbamoyldibenzo(b,f)azepine, CBZ, DTXSID4022731, NSC169864, 33CM23913M, NCGC00015234-11, CAS-298-46-4, SMR000058201, Stazepin, DTXCID902731, 5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A, Carbelan, Tegretol Cr, Carbamazepinum [INN-Latin], Carbamazepina [INN-Spanish], SMR001227191, HSDB 3019, SR-01000000229, Carbatrol extended-release, EINECS 206-062-7, BRN 1246090, Carbmazepine, Trimonil, Neurotop retard, UNII-33CM23913M, dibenzo[b,f]azepine-5-carboxamide, Tegretol (TN), Prestwick_104, Equetro (TN), Carbamazepine-[d2], Carbamazepine, powder, Opera_ID_72, Spectrum_000096, Carbamazepine [USAN:USP:INN:BAN:JAN], Prestwick0_000052, Prestwick1_000052, Prestwick2_000052, Prestwick3_000052, Spectrum2_000125, Spectrum3_000325, Spectrum4_000262, Spectrum5_000936, Carbamazepine (Carbatrol), Lopac-C-4024, ChemDiv1_018966, CARBAMAZEPINE [MI], CBChromo1_000350, Epitope ID:174842, Iminostilbene-N-carboxamide, CARBAMAZEPINE [INN], CARBAMAZEPINE [JAN], CARBAMAZEPINE [HSDB], CARBAMAZEPINE [USAN], Carbamazepine-[13C,15N], Lopac0_000292, Oprea1_790775, SCHEMBL21639, BSPBio_000203, BSPBio_001929, CARBAMAZEPINE [VANDF], KBioGR_000724, KBioSS_000516, MLS001055475, MLS001074172, MLS002548877, BIDD:GT0479, CARBAMAZEPINE [MART.], DivK1c_000388, DivK1c_003750, SPECTRUM1500159, SPBio_000170, SPBio_002124, CARBAMAZEPINE [USP-RS], CARBAMAZEPINE [WHO-DD], CARBAMAZEPINE [WHO-IP], BPBio1_000225, GTPL5339, SCHEMBL19838283, HMS501D10, HMS640O02, KBio1_000388, KBio2_000516, KBio2_003084, KBio2_005652, KBio3_001149, WLN: T C676 BNJ BVZ, Carbamazepine (JP17/USP/INN), CBZ;NSC 169864, SPD-417, Carbamazepine, analytical standard, NINDS_000388, HMS1568K05, HMS1920I17, HMS2090M07, HMS2091O19, HMS2095K05, HMS2233G16, HMS3039K09, HMS3259B21, HMS3260L06, HMS3372J13, HMS3657G03, HMS3712K05, HMS3747E03, Pharmakon1600-01500159, CARBAMAZEPINE [ORANGE BOOK], ACT02606, BCP21380, HY-B0246, 5-Carbomoyl-5H-dibenzo(b,f)azepine, CARBAMAZEPINE [EP MONOGRAPH], CARBAMAZEPINE [USP IMPURITY], Tox21_110104, Tox21_202273, Tox21_300195, Tox21_500292, AC2074, BDBM50003659, CARBAMAZEPINE [USP MONOGRAPH], CCG-38931, NSC755920, s1693, STK177357, STL453548, 11-benzo[b][1]benzazepinecarboxamide, 5H-Dibenz[b,f]azepine-5-carboxamine, Carbamazepine 1.0 mg/ml in Methanol, CARBAMAZEPINUM [WHO-IP LATIN], AKOS003235644, AKOS025397243, Tox21_110104_1, AC-9538, DB00564, KS-5146, LP00292, NC00679, NSC-755920, SDCCGSBI-0050280.P005, 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide, 5H-Dibenz[ b, f]azepine-5-carboxamide, CDS1_002710, IDI1_000388, 5H-Dibenzo[b,f]azepine-5-carboxamide #, NCGC00015234-01, NCGC00015234-02, NCGC00015234-03, NCGC00015234-04, NCGC00015234-05, NCGC00015234-06, NCGC00015234-07, NCGC00015234-08, NCGC00015234-09, NCGC00015234-10, NCGC00015234-12, NCGC00015234-13, NCGC00015234-14, NCGC00015234-15, NCGC00015234-16, NCGC00015234-18, NCGC00015234-19, NCGC00015234-33, NCGC00023877-03, NCGC00023877-04, NCGC00023877-05, NCGC00023877-06, NCGC00023877-07, NCGC00023877-08, NCGC00253982-01, NCGC00259822-01, NCGC00260977-01, BC166161, SY002823, (z)-5h-dibenzo[b,f]azepine-5-carboxamide, SBI-0050280.P004, 5H-dibenzo[b,f]azepine-5-carboximidic acid, DB-047659, Dibenzo[b,f]azepine-5-carboxylic acid amide, EU-0100292, FT-0602927, FT-0696814, SW220141-1, EN300-21678, OXCARBAZEPINE IMPURITY A [EP IMPURITY], BIM-0050280.0001, C 4024, C06868, Carbamazepine, meets USP testing specifications, D00252, 5H-Dibenz(b,f)azepine-5-carboxamide maleic acid, 5H-Dibenz(b,f)azepine-5-carboxamide oxalic acid, AB00051931-17, AB00051931-18, AB00051931_19, AB00051931_20, A820074, Q410412, carbamazepine host structure with maleic acid removed, carbamazepine host structure with oxalic acid removed, Q-200792, SR-01000000229-2, SR-01000000229-4, SR-01000000229-7, 5H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acid, BRD-K71799949-001-06-7, F0348-2551, Z104508594, carbamazepine host structure with DL-tartaric acid removed, Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine), carbamazepine host structure with 4-hydroxybenzoic acid removed, Carbamazepine, British Pharmacopoeia (BP) Reference Standard, Carbamazepine, European Pharmacopoeia (EP) Reference Standard, Carbamazepine, United States Pharmacopeia (USP) Reference Standard, 2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide, Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material, N6W

Pubchem:PUBCHEM:2554

Id:8cf7f4e8-9b40-5aa5-86e2-ccd603551042

Description:nan